HIV molecular immunology database
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172) | B57 human epitope |
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172) | B57 human epitope |
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172) | B57 human epitope |
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172) | human epitope |
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172) | macaque epitope |
NAWVKVVEEKAFSPEVIPMFSA
|
Gag(153-174) | B57 human epitope |
AWVKVIEEKAFSPEV
|
Gag(154-168) | human epitope |
nAWVKVvEEKAFSPE
|
Gag(154-168) | subtype-specific non-susceptible form |
AWVKVVEEKGFNPEV
|
Gag(154-168) | human epitope |
WVKVIEEKAFSPEVIPMF
|
Gag(155-172) | C*16 human epitope |
WVKVIEEKAFSPEVIPMF
|
Gag(155-172) | human epitope |
VKVIEEKAFSPEVIP
|
Gag(156-170) | human epitope |
VKVIEEKAFSPEVIPMFT
|
Gag(156-173) | human epitope |
KVVEEKAFSPEVIPM
|
Gag(157-171) | B44 human epitope |
KVVEEKAFSPEVIPM
|
Gag(157-171) | B*57:01, B*57:03 human epitope |
KVVEEKAFSPEVIPM
|
Gag(157-171) | human epitope |
KVVEEKAFSPEVIPM
|
Gag(157-171) | human epitope |
KVVEEKAFSPEVIPM
|
Gag(157-171) | human epitope |
VIEEKAFSPEVIPMF
|
Gag(158-172) | human epitope |
VvEEKgFnPEVIPMF
|
Gag(158-172) | subtype-specific susceptible form |
VVEEKAFSPEVIPMFSALS
|
Gag(158-176) | macaque epitope |
IEEKAFSPEV
|
Gag(159-168) | human epitope |
IEEKAFSPEVI
|
Gag(159-169) | B*45:01 human epitope |
IEEKAFSPEVI
|
Gag(159-169) | B*45:01, B*57:01, B*57:03 human epitope |
MEEKAFSPEVIPMFT
|
Gag(159-173) | human epitope |
EEKAFSPEV
|
Gag(160-168) | A*30 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*14 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*35:01, B*35:08 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*39 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*42:01 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*44, B*44:15, B*45:01 human epitope |
EEKAFSPEV
|
Gag(160-168) | B44 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*44:15 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*44:15 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*45:01 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*45:01 human epitope |
EEKAFSPEV
|
Gag(160-168) | B*81 human epitope |
EEKAFSPEV
|
Gag(160-168) | human epitope |
EEKAFSPEV
|
Gag(160-168) | human epitope |
EEKAFSPEV
|
Gag(160-168) | human epitope |
EEKAFSPEVIP
|
Gag(160-170) | B*57 human epitope |
EEKAFSPEVIPMFSA
|
Gag(160-174) | human epitope |
EEKAFSPEVIPMFSA
|
Gag(160-174) | human epitope |
EEKAFSPEVIPMFSALSEGA
|
Gag(160-179) | B27 human epitope |
EKAFSPEV
|
Gag(161-168) | B*44, B*44:15, B*45:01 human epitope |
EKAFSPEV
|
Gag(161-168) | human epitope |
EKAFSPEVIPM
|
Gag(161-171) | macaque epitope |
{D}KAFSPEVIPMF
|
Gag(161-172) | B*57:03 human epitope |
{e}KAFSPEVIPMF
|
Gag(161-172) | HLA association |
EKAFSPEVIPMF
|
Gag(161-172) | B*57:03, B*58:01 human epitope |
dKAFSPEVIPMF
|
Gag(161-172) | HLA association |
EKsFSPEVIPMF
|
Gag(161-172) | HLA association |
EKAFnPEVIPMF
|
Gag(161-172) | HLA association |
EKgFSPEVIPMF
|
Gag(161-172) | HLA association |
EKAFkPEVIPMF
|
Gag(161-172) | HLA association |
EKAFSPEVIPMFSAL
|
Gag(161-175) | human epitope |
EKAFSPEVIPMFSAL
|
Gag(161-175) | human epitope |
EKAFSPEVIPMFSAL
|
Gag(161-175) | human epitope |
EKGFNPEVIPMFSAL
|
Gag(161-175) | human epitope |
EKAFSPEVIPMFSALSEGAT
|
Gag(161-180) | B*57:01 human epitope |
EKAFSPEVPMFTALSEGAT
|
Gag(161-180) | human epitope |
KAFSPEVI
|
Gag(162-169) | B*57 human epitope |
KAFSPEVI
|
Gag(162-169) | B*57 human epitope |
KAFSPEVI
|
Gag(162-169) | B*57 human epitope |
KAFSPEVI
|
Gag(162-169) | B*57, B*57:01, B*57:03 human epitope |
KAFSPEVI
|
Gag(162-169) | B57 human epitope |
KAFSPEVI
|
Gag(162-169) | B*57:03 human epitope |
KAFSPEVI
|
Gag(162-169) | B*57:03 human epitope |
KAFSPEVI
|
Gag(162-169) | B*57:03 human epitope |
KAFSPEVI
|
Gag(162-169) | human epitope |
KAFSPEVI
|
Gag(162-169) | human epitope |
RAFSPEVIP
|
Gag(162-170) | B57 human epitope |
KKFGAEVVP
|
Gag(162-170) | Mane A*10 macaque epitope |
KKFGAEVVP
|
Gag(162-170) | Mane A*10 macaque epitope |
KAFSPEVIP
|
Gag(162-170) | human epitope |
KAFSPEVIPM
|
Gag(162-171) | C*03:04 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | A*02:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*48:01, B*57:03 epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KgFSPEVIPMF
|
Gag(162-172) | HLA association; escape documented in this paper; non-susceptible form |
KnFSPEVIPMF
|
Gag(162-172) | HLA association; escape documented in this paper; non-susceptible form |
KgFnPEVIPMF
|
Gag(162-172) | HLA association; escape documented in this paper; non-susceptible form |
KgFkPEVIPMF
|
Gag(162-172) | HLA association; diminished HLA binding or increased off-rate; escape documented in this paper; non-susceptible form |
KsFSPEtIPMF
|
Gag(162-172) | observed variant |
KAFSPEiIPMF
|
Gag(162-172) | observed variant |
KAFnPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KnFSPEVIPMF
|
Gag(162-172) | diminished HLA binding or increased off-rate; literature escape |
rAFSPEiIPMF
|
Gag(162-172) | diminished HLA binding or increased off-rate; literature escape |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF{t}
|
Gag(162-172) | literature escape; non-susceptible form; susceptible form |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KGFNPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KGFNPEVvPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSaEVIPMF
|
Gag(162-172) | TCR related mutation |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57, B*57:01, B*57:03, B*58, B*58:01, B*63 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57, B*58 epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57, B*58:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57, B*58:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57, B*58:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57, B*58:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KvFSPEVIPMF
|
Gag(162-172) | observed variant |
eAFSPEVIPMF
|
Gag(162-172) | observed variant |
KtFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57, B58 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57, B58 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*58:01, B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*58:01, B57 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B57, B63 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
rAFSPEVIPMF
|
Gag(162-172) | susceptible form |
KnFSPEVIPMF
|
Gag(162-172) | non-susceptible form; susceptible form |
KgFSPEVIPMF
|
Gag(162-172) | susceptible form |
KAFSPEiIPMF
|
Gag(162-172) | susceptible form |
KAFnPEVIPMF
|
Gag(162-172) | non-susceptible form; susceptible form |
KgFnPEVIPMF
|
Gag(162-172) | non-susceptible form; susceptible form |
KAFnPEiIPMF
|
Gag(162-172) | non-susceptible form; susceptible form |
KAFSPgVIPMF
|
Gag(162-172) | non-susceptible form |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KGFNPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMs
|
Gag(162-172) | observed variant |
KAFSPEVIPMt
|
Gag(162-172) | observed variant |
KAFSPEiIPMF
|
Gag(162-172) | observed variant |
KAsSPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMs
|
Gag(162-172) | observed variant |
KAFSPEVIPMt
|
Gag(162-172) | observed variant |
KAFSPEiIPMF
|
Gag(162-172) | observed variant |
KAsSPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KsFSPEVIPMF
|
Gag(162-172) | observed variant |
KgFnPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
{k}KAFSPEVIPMF
|
Gag(162-172) | observed variant |
{d}KAFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF{a}
|
Gag(162-172) | observed variant |
{q}KAFSPEVIPMF
|
Gag(162-172) | observed variant |
{s}KAFSPEVIPMF
|
Gag(162-172) | observed variant |
{t}KAFSPEVIPMF
|
Gag(162-172) | observed variant |
{a}KAFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFaPEVIPMF{t}
|
Gag(162-172) | observed variant |
KAFSPEVIPMF{g}
|
Gag(162-172) | observed variant |
KAFSPEVIPMF{t}
|
Gag(162-172) | observed variant |
rAFSPEVIPMF{a}
|
Gag(162-172) | observed variant |
KAFSPEVIPMF{n}
|
Gag(162-172) | observed variant |
KnFSPEVIPMF{v}
|
Gag(162-172) | observed variant |
KAFSPEVIPMF{q}
|
Gag(162-172) | observed variant |
KnFSPEVIPMF{t}
|
Gag(162-172) | observed variant |
KAFSPEVIPMF{v}
|
Gag(162-172) | observed variant |
rAFSPEVIPMF{t}
|
Gag(162-172) | observed variant |
KAFaPEVIPMF{q}
|
Gag(162-172) | observed variant |
rAFSPEVIPMF{q}
|
Gag(162-172) | observed variant |
KAFSPEVvPMF{a}
|
Gag(162-172) | observed variant |
KAFaPEVIPMF
|
Gag(162-172) | observed variant |
KAFSaEVvPMF
|
Gag(162-172) | observed variant |
KnFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFqPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEiIPMF
|
Gag(162-172) | observed variant |
rAFSPEiIPMF
|
Gag(162-172) | observed variant |
KAFSPEtIPMF
|
Gag(162-172) | observed variant |
KAFSPEVvPMF
|
Gag(162-172) | observed variant |
rAFaPEVIPMF
|
Gag(162-172) | observed variant |
rAFSPEVIPMF
|
Gag(162-172) | observed variant |
rgFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFcPEVIPMF
|
Gag(162-172) | observed variant |
KqFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFtPEVIPMF
|
Gag(162-172) | observed variant |
KgFaPEVIPMF
|
Gag(162-172) | observed variant |
KgFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFSaEVIPMF
|
Gag(162-172) | observed variant |
KAFmPEVIPMF
|
Gag(162-172) | observed variant |
KgFqPEVIPMF
|
Gag(162-172) | observed variant |
KeFSPEVIPMF
|
Gag(162-172) | observed variant |
KsFSPEtIPMF
|
Gag(162-172) | observed variant |
KdFSPEVIPMF
|
Gag(162-172) | observed variant |
KsFSPEVIPfF
|
Gag(162-172) | observed variant |
KgFrPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEcIPMF
|
Gag(162-172) | observed variant |
KAFnPEVIPMF
|
Gag(162-172) | observed variant |
KsFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFvPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEcvPMF
|
Gag(162-172) | observed variant |
KtFSPEVIPMF
|
Gag(162-172) | observed variant |
KcFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:02, B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KgFnPEVIPMF
|
Gag(162-172) | subtype-specific susceptible form |
KAlSPEVIPMF
|
Gag(162-172) | subtype-specific susceptible form |
KAFSPEVIPvF
|
Gag(162-172) | subtype-specific susceptible form |
KAFnPEiIPMF
|
Gag(162-172) | subtype-specific susceptible form |
KAFSPEiIPMF
|
Gag(162-172) | subtype-specific susceptible form |
KAFSqEVIPMF
|
Gag(162-172) | diminished response; subtype-specific susceptible form |
rgFSPEVIPMF
|
Gag(162-172) | observed variant |
rgsSPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KgFSPEVIPMF
|
Gag(162-172) | diminished HLA binding or increased off-rate; diminished response; escape documented in this paper; replicative capacity reduced |
KgFnPEVIPMF
|
Gag(162-172) | compensatory mutation; escape documented in this paper; replicative capacity reduced |
KsFSPEVIPMF
|
Gag(162-172) | diminished HLA binding or increased off-rate; diminished response; escape documented in this paper; replicative capacity reduced |
KxFkPEVIPMF
|
Gag(162-172) | compensatory mutation; escape documented in this paper |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KgFnPEVIPMF
|
Gag(162-172) | observed variant |
KnFSPEVIPMF
|
Gag(162-172) | observed variant |
KsFSPEVIPMF
|
Gag(162-172) | observed variant |
KgFSPEVIPMF
|
Gag(162-172) | observed variant |
KgFkPEVIPMF
|
Gag(162-172) | observed variant |
KsFSPEtIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KgFnPEVIPMF
|
Gag(162-172) | subtype-specific non-susceptible form; subtype-specific susceptible form |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KgFSPEVIPMF
|
Gag(162-172) | subtype-specific non-susceptible form; subtype-specific susceptible form |
KnFSPEVIPMF
|
Gag(162-172) | subtype-specific non-susceptible form; subtype-specific susceptible form |
KsFSPEVIPMF
|
Gag(162-172) | observed variant |
KgFnPEVIPMF
|
Gag(162-172) | diminished HLA binding or increased off-rate; subtype-specific non-susceptible form; subtype-specific susceptible form |
KgFkPEVIPMF
|
Gag(162-172) | diminished HLA binding or increased off-rate; subtype-specific non-susceptible form; subtype-specific susceptible form |
KsFSPEtIPMF
|
Gag(162-172) | observed variant |
KAFSPEiIPMF
|
Gag(162-172) | subtype-specific susceptible form |
KsFSPEiIPMF
|
Gag(162-172) | observed variant |
KAFnPEVIPMF
|
Gag(162-172) | observed variant |
KAFnPEiIPMF
|
Gag(162-172) | observed variant |
rAFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPkVIPMF
|
Gag(162-172) | observed variant |
KAlSPEVIPMF
|
Gag(162-172) | susceptible form |
KAFSPEVIPvF
|
Gag(162-172) | susceptible form |
KAFSqEVIPMF
|
Gag(162-172) | non-susceptible form |
KAFSPEaIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KgFSPEVIPMF
|
Gag(162-172) | literature escape; replicative capacity reduced; subtype-specific non-susceptible form |
KAFnPEVIPMF
|
Gag(162-172) | literature escape; replicative capacity reduced; subtype-specific non-susceptible form |
KgFnPEVIPMF
|
Gag(162-172) | literature escape; replicative capacity reduced; subtype-specific non-susceptible form |
KAFSPEVIPMF{t}
|
Gag(162-172) | literature escape; replicative capacity reduced; subtype-specific non-susceptible form |
KsFSPEiIPMF
|
Gag(162-172) | observed variant |
KsFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFkPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEiIPMF
|
Gag(162-172) | observed variant |
KAFnPEVIPMF{i}
|
Gag(162-172) | observed variant |
KAFSPEVIPMF{a}
|
Gag(162-172) | observed variant |
KgFnPEVIPMF{a}
|
Gag(162-172) | observed variant |
KAFSPEiIPMF{t}
|
Gag(162-172) | observed variant |
KsFSPEVIPMF{t}
|
Gag(162-172) | observed variant |
KnFSPEVIPMF{t}
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:01, B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KxFSPEVIPMF
|
Gag(162-172) | observed variant |
KAFxPEVIPMF
|
Gag(162-172) | observed variant |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KnFSPEVIPMF
|
Gag(162-172) | non-susceptible form; susceptible form |
rAFSPEVIPMF
|
Gag(162-172) | non-susceptible form; susceptible form |
KgFnPEVIPMF
|
Gag(162-172) | non-susceptible form; susceptible form |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*57:03 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B58 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B58 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B58 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*58:01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | B*63 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | C*01 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | C*14 human epitope |
KAFSPEVIPMF
|
Gag(162-172) | human epitope |
KAFSPEVIPMF
|
Gag(162-172) | human epitope |
KAFSPEVIPMF
|
Gag(162-172) | human epitope |
KAFSPEVIPMF
|
Gag(162-172) | human epitope |
KAFSPEVIPMF
|
Gag(162-172) | human epitope |
KAFSPEVIPMF
|
Gag(162-172) | human epitope |
KAFSPEVIPMF
|
Gag(162-172) | human epitope |
KAFSPEVIPMF
|
Gag(162-172) | human epitope |
AFSPEVIPMFT
|
Gag(163-173) | human epitope |
AFSPEVIPMFSALS
|
Gag(163-176) | human epitope |
AFSPEVIPMFTALSE
|
Gag(163-177) | human epitope |
AFSPEVIPMFTALSE
|
Gag(163-177) | human epitope |
AFSPEVIPMFTALSEGA
|
Gag(163-179) | C*14 human epitope |
AFSPEVIPMFSALSEGA
|
Gag(163-179) | human epitope |
AFSPEVIPMFSALSEGA
|
Gag(163-179) | human epitope |
AFSPEVIPMFSALSEGA
|
Gag(163-179) | human epitope |
AFSPEVIPMFtALSEGA
|
Gag(163-179) | subtype-specific susceptible form |
AFSPEVIPMFSALSEGATPQ
|
Gag(163-182) | human epitope |
AFSPEVIPMFSALSEGATPQ
|
Gag(163-182) | human epitope |
AFSPEVIPMFSALSEGATPQ
|
Gag(163-182) | human epitope |
AFSPEVIPMFSALSEGATPQ
|
Gag(163-182) | human epitope |
FSPEVIPMF
|
Gag(164-172) | B*57 human epitope |
FSPEVIPMF
|
Gag(164-172) | B*57 human epitope |
FSPEVIPMF
|
Gag(164-172) | B*57, B*58, B*63 human epitope |
FSPEVIPMF
|
Gag(164-172) | B57 human epitope |
FSPEVIPMF
|
Gag(164-172) | B57, B58, B63 human epitope |
FSPEVIPMF
|
Gag(164-172) | C*14 human epitope |
FSPEVIPMF
|
Gag(164-172) | Mamu-A*01 macaque epitope |
FnPEVIPMF
|
Gag(164-172) | susceptible form |
FSPEiIPMF
|
Gag(164-172) | susceptible form |
qSPEVIPMF
|
Gag(164-172) | susceptible form |
FnPEiIPMF
|
Gag(164-172) | susceptible form |
FnPEiIPMF
|
Gag(164-172) | susceptible form |
FSPqVIPMF
|
Gag(164-172) | susceptible form |
FSPEVIPMF
|
Gag(164-172) | human epitope |
FSPEVIPMF
|
Gag(164-172) | human epitope |
FSPEVIPMFS
|
Gag(164-173) | C*03:04 human epitope |
FSPEVIPMFSALSEGATP
|
Gag(164-181) | human epitope |
FSPEVIPMFSALSEGATP
|
Gag(164-181) | human epitope |
SPEVIPMF
|
Gag(165-172) | human epitope |
SPEVIPMFASLSEGA
|
Gag(165-179) | A2 human epitope |
SPEVIPMFSALSEGA
|
Gag(165-179) | human epitope |
SPEVIPMFSALSEGA
|
Gag(165-179) | human epitope |
SPEVIPMFSALSEGA
|
Gag(165-179) | mouse epitope |
PEVIPMFSAL
|
Gag(166-175) | C*03:04 human epitope |
PEVIPMFaAL
|
Gag(166-175) | observed variant |
PEVIPMFmAL
|
Gag(166-175) | observed variant |
PEVIPMFtAL
|
Gag(166-175) | observed variant |
PEVIPMFSALSEGATP
|
Gag(166-181) | epitope |
EVIPMFSAL
|
Gag(167-175) | A*25 human epitope |
EVIPMFSAL
|
Gag(167-175) | A*26 human epitope |
EVIPMFSAL
|
Gag(167-175) | A*26 human epitope |
EVIPMFSAL
|
Gag(167-175) | A*26, A*26:01, A*26:02, A*26:03, C*01, C*01:02 human epitope |
EVIPMFtAL
|
Gag(167-175) | HLA association; processing |
EVIPMFTAL
|
Gag(167-175) | A*26, A*26:01, A*26:02, A*26:03, C*01, C*01:02 human epitope |
EVIPMFsAL
|
Gag(167-175) | HLA association; processing |
EVIPMFSAL
|
Gag(167-175) | A26 human epitope |
EVIPMFSAL
|
Gag(167-175) | A26 human epitope |
EVIPMFSAL
|
Gag(167-175) | A26 human epitope |
EVIPMFSAL
|
Gag(167-175) | A26 human epitope |
EVIPMFSAL
|
Gag(167-175) | A26 human epitope |
EVIPMFSAL
|
Gag(167-175) | A*26:01 epitope |
EVIPMFTAL
|
Gag(167-175) | A*26:01 human epitope |
EVIPMFSAL
|
Gag(167-175) | A*26:01 human epitope |
EVIPMFaAL
|
Gag(167-175) | observed variant |
EVIPMFtAL
|
Gag(167-175) | observed variant |
EVIPMFSAL
|
Gag(167-175) | A*26:01 human epitope |
EVIPMFTAL
|
Gag(167-175) | A*26:01 human epitope |
EVIPMFSAL
|
Gag(167-175) | A*26:01, A*26:02, A*26:03 human epitope |
EVIPMFSAL
|
Gag(167-175) | A*26:01, A*26:02, A*26:03 human epitope |
EVIPMFSAL
|
Gag(167-175) | A*26:01, A*26:03 human epitope |
EVIPMFaAL
|
Gag(167-175) | escape documented in this paper; TCR related mutation |
EVIPMFtAL
|
Gag(167-175) | escape documented in this paper; TCR related mutation |
kVIPMFSAL
|
Gag(167-175) | diminished HLA binding or increased off-rate |
EiIPMFSAL
|
Gag(167-175) | observed variant |
EVIPvFSAL
|
Gag(167-175) | observed variant |
gVIPMFSAL
|
Gag(167-175) | observed variant |
EgIPMFSAL
|
Gag(167-175) | observed variant |
EVIPMFpAL
|
Gag(167-175) | observed variant |
EiIPMFaAL
|
Gag(167-175) | observed variant |
EmIPMFaAL
|
Gag(167-175) | observed variant |
EVIPMFttL
|
Gag(167-175) | observed variant |
EiIPMFtAL
|
Gag(167-175) | observed variant |
EeIPMFtAL
|
Gag(167-175) | observed variant |
EVIPiFtAL
|
Gag(167-175) | observed variant |
EVIPvFtAL
|
Gag(167-175) | observed variant |
EiIPiFtAL
|
Gag(167-175) | observed variant |
EVIPMFSAL
|
Gag(167-175) | A*26:02 epitope |
EVIPMFSAL
|
Gag(167-175) | A*26:03 epitope |
EVIPMFTAL
|
Gag(167-175) | A*26:38 human epitope |
EVIPMFSAL
|
Gag(167-175) | C*01 human epitope |
EVIPMFSAL
|
Gag(167-175) | Cw3 human epitope |
EVIPMFAAL
|
Gag(167-175) | human epitope |
EVIPMFSAL
|
Gag(167-175) | human epitope |
EVIPMFSAL
|
Gag(167-175) | human epitope |
EVIPMFSAL
|
Gag(167-175) | human epitope |
EVIPMFSAL
|
Gag(167-175) | human epitope |
EVIPMFSALSEGATP
|
Gag(167-181) | human epitope |
EVIPMFTALSEGATP
|
Gag(167-181) | human epitope |
VIPMFSAL
|
Gag(168-175) | B*15:16 human epitope |
VIPMFSAL
|
Gag(168-175) | B*18 human epitope |
VIPMFSAL
|
Gag(168-175) | C*01 human epitope |
VIPMFSAL
|
Gag(168-175) | C*01 human epitope |
VIPMFSAL
|
Gag(168-175) | C*01:02 human epitope |
VIPMFSAL
|
Gag(168-175) | C*01:02 human epitope |
VIPMFSAL
|
Gag(168-175) | C*01:02 human epitope |
VIPMFSAL
|
Gag(168-175) | C*01:02 human epitope |
VIPMSFAL
|
Gag(168-175) | C*01:02 human epitope |
VIPMtFAL
|
Gag(168-175) | HLA association; diminished response; escape documented in this paper |
VIPMFSAL
|
Gag(168-175) | C*01:02 human epitope |
VIPMFSAL
|
Gag(168-175) | C*01:02, Cw1 human epitope |
VIPMFSAL
|
Gag(168-175) | C*14 human epitope |
VIPMFSAL
|
Gag(168-175) | Cw1 human epitope |
VIPMFSAL
|
Gag(168-175) | Cw1 human epitope |
VIPMFSAL
|
Gag(168-175) | Cw1, Cw2 human epitope |
VIPMFAAL
|
Gag(168-175) | human epitope |
VIPMFSAL
|
Gag(168-175) | human epitope |
VIPMFSAL
|
Gag(168-175) | human epitope |
VIPMFSAL
|
Gag(168-175) | human epitope |
VIPMFSALS
|
Gag(168-176) | human epitope |
VIPMFSALSEGATPQDLN
|
Gag(168-185) | mouse epitope |
VIPMFtALSEGATPQDLN
|
Gag(168-185) | subtype-specific susceptible form |
VIPMFSALSEGATPQDLN
|
Gag(168-185) | macaque epitope |
VIPMFSALSEGATPQDLN
|
Gag(168-185) | human, macaque epitope |
VIPMFTALSEGATPQDLN
|
Gag(168-185) | human, macaque epitope |
IPMFSALSEG
|
Gag(169-178) | B7 human epitope |
IPMFSALSEGATPQD
|
Gag(169-183) | A2, B44 human epitope |
IPMFSALSEGATPQDL
|
Gag(169-184) | B12 human epitope |
IPMFSALSEGATPDQL
|
Gag(169-184) | B44 human epitope |
IPMFSALSEGATPQDL
|
Gag(169-184) | B44 human epitope |
PMFSALSEG
|
Gag(170-178) | human epitope |
PMFTALSEGAT
|
Gag(170-180) | human epitope |
PMFTALSEGATPQDLNTM
|
Gag(170-187) | C*08 human epitope |
PMFSALSEGATPQDLNTM
|
Gag(170-187) | human epitope |
PMFSALSEGATPQDLNTM
|
Gag(170-187) | human epitope |
PMFSALSEGATPQDLNTM
|
Gag(170-187) | human epitope |
PMFtALSEGATPQDLNTM
|
Gag(170-187) | subtype-specific susceptible form |
MFSALSEGA
|
Gag(171-179) | H-2d mouse epitope |
MFSALSEGATPHDLN
|
Gag(171-185) | human epitope |
MFTALSEGTPQDLNTMLNT
|
Gag(171-190) | human epitope |
FSALSEGAT
|
Gag(172-180) | human epitope |
FSALSEGATPQDLNT
|
Gag(172-186) | human epitope |
TALSEGATP
|
Gag(173-181) | E*01:03 human epitope |
SALSEGATPQDLNTM
|
Gag(173-187) | B44 human epitope |
SALSEGATPQDLNTM
|
Gag(173-187) | human epitope |
QALSEGCTPYDINQML
|
Gag(173-188) | human epitope |
SALSEGATPQDLNTML
|
Gag(173-188) | human epitope |
SALSEGATPQDLNMMLNIVG
|
Gag(173-192) | B*81:01 human epitope |
SALSEGATPQDLNtMLNtVG
|
Gag(173-192) | observed variant |
SALSEGATPQDLNTMLNTVG
|
Gag(173-192) | human epitope |
SALSEGATPQDLNTMLNTVG
|
Gag(173-192) | human epitope |
SALSEGATPQDLNmMLNiVG
|
Gag(173-192) | observed variant |
tALSEGATPQDLNTMLNTVG
|
Gag(173-192) | inferred escape |
SALSEGATPQDLNTMLNTVG
|
Gag(173-192) | human epitope |
SALSEGATPQDLNTMLNTVG
|
Gag(173-192) | human epitope |
SALSEGATPQDLNTMLNTVGGH
|
Gag(173-194) | B14 human epitope |
ALSEGATPQDL
|
Gag(174-184) | human epitope |
ALSEGATPQDLNMM
|
Gag(174-187) | human epitope |
LSEGATPQD
|
Gag(175-183) | human epitope |
LSEGATPQDL
|
Gag(175-184) | B42, B44 human epitope |
LSEGATPQDL
|
Gag(175-184) | B*44:03 human epitope |
LSEGATPQDLNTMLN
|
Gag(175-189) | human epitope |